On Wednesday, Cintas earned an upgrade to its Relative Strength (RS) Rating, from 69 to 72.
IBD's unique rating tracks price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains tend to have an RS Rating of over 80 as they launch their biggest climbs. See if Cintas can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Cintas is working on a consolidation with a 228.12 buy point. See if it can break out in heavy volume.
Cintas saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 18% to 21%. Revenue rose from 7% to 8%.
The company holds the No. 6 rank among its peers in the Commercial Services-Outsourcing industry group. ExlService Holdings, HealthEquity and Red Violet are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
